BioSpace News Archive

Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia” or the “Company”) is pleased to announce the results of its annual meeting of shareholders (the “Meeting”) held on December 15, 2022.

Centogene N.V. has received notification from the Nasdaq Stock Market LLC Listing Qualifications Department that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5450 since the closing bid price for the Company’s common shares listed on Nasdaq was below US$1.00 for 30 consecutive business days.

Taysha Gene Therapies, Inc., a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations, announced executive leadership changes effective immediately.

Tarsus Pharmaceuticals, Inc. today announced that Tarsus will be added to the NASDAQ Biotechnology Index ® (NASDAQ: NBI), effective December 19, 2022.